Unknown PHASE4 INTERVENTIONAL 2-arm NCT03070847

Low vs. Very Low Dose of Prophylactic Tranexamic Acid for Bleeding Reduction During Rhinoplasty

Impact of Prophylactic Tranexamic Acid on Intra and Postoperational Bleeding Reduction in Patients Undergoing Rhinoplasty Surgery. Low (10mg/kg) and Very Low (5mg/kg) Dose Comparison

Sponsor: Bartłomiej Wódarski

Conditions Bleeding Reduction

Interventions Sodium Chloride Tranexamic Acid

Updated 7 times since 2017 Last updated: Aug 28, 2017 Started: Mar 1, 2017 Primary completion: Mar 31, 2019 Completion: Mar 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03070847, this PHASE4 trial focuses on Bleeding Reduction and remains ongoing. Sponsored by Bartłomiej Wódarski, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Sep 2019 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jun 2018 — Sep 2019 [monthly]

Recruiting PHASE4

▶ Show 2 earlier versions

Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE4
Apr 2017 — Sep 2017 [monthly]

Recruiting PHASE4

First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bartłomiej Wódarski

Data source: Centre of Postgraduate Medical Education

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland